Agnieszka Zalewska

Agnieszka Zalewska

Auto-generated profile, based on publicly available information

Agnieszka Zalewska

Szpital Morski Im. PCK, Gdynia, Poland

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
MFMagdalena Fidelis
Magdalena Fidelis
MWMaria Wojcieszek
Maria Wojcieszek
KGKatarzyna Gondek
Katarzyna Gondek
DGDominika Gacka
Dominika Gacka
AZAgnieszka Zalewska
Agnieszka Zalewska
ZTZuzanna Tanç
Zuzanna Tanç
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have advanced from incretin-based therapies for type 2 diabetes to multifaceted treatments addressing obesity, cardiovascular disease, and emerging neuropsychiatric conditions. This review examines their physiological mechanisms, pharmacological profiles, and clinical outcomes based on data through early 2026. GLP-1 RAs mimic the incretin effect, enhancing insulin secretion, delaying gastric emptying, and modulating central reward pathways in the mesolimbic system. Approved agents like semaglutide and tirzepatide achieve 15-25% weight loss, reduce major adverse cardiovascular events by 12-26%, and show promise in heart failure with preserved ejection fraction and chronic kidney disease. Recent trials indicate potential in alcohol use disorder, with semaglutide reducing heavy drinking and cravings, though cognitive benefits in major depressive disorder remain unproven. Safety analyses from large cohorts (2024-2025) confirm no increased thyroid cancer risk (HR 0.81-0.93), and FDA reviews (2026) find no causal suicidality link. Overall, GLP-1 RAs bridge metabolic and behavioral health, supporting a unified view of energy regulation. Ongoing research on patient responders and targeted analogues will guide their integration into care for metabolic psychiatry, emphasizing balanced risk assessment.

10 December 2024 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
ALAnna Litwińska-Kmiecik
Anna Litwińska-Kmiecik
AZAgnieszka Zalewska
Agnieszka Zalewska

12 December 2024 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
AZAgnieszka Zalewska
Agnieszka Zalewska
ALAnna Litwińska-Kmiecik
Anna Litwińska-Kmiecik
AWAlicja Wiśniewska
Alicja Wiśniewska

28 November 2024 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
ALAnna Litwińska-Kmiecik
Anna Litwińska-Kmiecik
AZAgnieszka Zalewska
Agnieszka Zalewska
AWAlicja Wiśniewska
Alicja Wiśniewska

6 January 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
MFMagdalena Fidelis
Magdalena Fidelis
AZAgnieszka Zalewska
Agnieszka Zalewska
MZMaria Zadrożna-Dyńka
Maria Zadrożna-Dyńka
MDMarcin Dyńka
Marcin Dyńka
MWMaria Wojcieszek
Maria Wojcieszek
ZTZuzanna Tanç
Zuzanna Tanç
The global shift to remote and hybrid work models from 2021 to 2025, comparable to the Industrial Revolution in scale, has entrenched flexibility while introducing unintended physiological, psychological, and sociological costs. This narrative review synthesizes data from the International Labour Organization, World Health Organization, Eurofound, and peer-reviewed literature (2020-2025) to analyze these externalities among college-educated workers. Drawing on the Global Survey of Working Arrangements (G-SWA), work-from-home stabilized at 1.27 days/week globally (27% of U.S. workdays), with regional disparities (e.g., 1.5-1.9 days in English-speaking economies vs. 0.5-1.0 in Asia) influencing exposure. The "Infinite Workday" (Microsoft, 2025) - characterized by 117 emails, 153 Teams messages, and 275 daily interruptions - exacerbates issues like Work-Related Musculoskeletal Disorders (WRMSDs, prevalence 61.2%-72%, e.g., neck pain 50.4%-58.9%) and Computer Vision Syndrome (CVS, pooled 69.0%, 95% CI 62.3-75.3). Psychologically, technostress (50-70% prevalence for techno-overload) and Zoom fatigue (40-70%) blur boundaries, while sedentary isolation elevates inflammation (CRP/IL-6) and depression risk (20-43%). Sociologically, women face double burdens (promotion gap 37% vs. 49% for men), Gen Z reports 27% loneliness, and individualism explains 29% WFH variance. Economically, costs include $380.9 billion U.S. MSK healthcare and $9.6 trillion global disengagement opportunity (Gallup, 2025). Without ergonomic (e.g., TuMeke's 42% injury reduction), policy ("Right to Disconnect" reducing stress 10-30%), and cultural interventions, flexibility's dividends risk erosion by chronic morbidity.

6 January 2026 in International Journal of Innovative Technologies in Social Science
Verified
Journal Article
Open access
MFMagdalena Fidelis
Magdalena Fidelis
AZAgnieszka Zalewska
Agnieszka Zalewska
MZMaria Zadrożna-Dyńka
Maria Zadrożna-Dyńka
MDMarcin Dyńka
Marcin Dyńka
MWMaria Wojcieszek
Maria Wojcieszek
ZTZuzanna Tanç
Zuzanna Tanç
Global plastic production has led to widespread environmental contamination, with synthetic polymers fragmenting into microplastics (MPs) and nanoplastics (NPs). These particles have been detected in human tissues, raising questions about their health effects. This narrative review synthesizes biomonitoring studies on MP/NP accumulation, with a focus on reproductive systems. Data from recent research show polymers in blood, lungs, placentas, breast milk, testes, and brain, linked to exposure routes such as inhalation and ingestion. The review examines potential translocation across barriers like the placenta and blood-brain barrier, as well as toxicity mechanisms, including endocrine-disrupting chemical release, oxidative stress via the Nrf2 pathway, and cellular disruption. In reproductive health, evidence indicates MP presence in ovarian follicular fluid and associations with reduced sperm quality, suggesting potential contributions to fertility trends. The review also addresses debates on neuro-accumulation and economic costs of related diseases. Findings highlight MPs as a public health concern, calling for policy measures and updated risk assessments.